Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms

Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms

3′-5′ cyclic nucleotide phosphodiesterases (PDEs) are a family of evolutionarily conserved cAMP and/or cGMP hydrolyzing enzymes, components of transduction pathways regulating crucial aspects of cell life. Among them, cGMP-specific PDE5—being a regulator of vascular smooth muscle contraction—is the...

Full description

Bibliographic Details
Main Authors:	Silvia Cardarelli, Adriana Erica Miele, Federica Campolo, Mara Massimi, Patrizia Mancini, Stefano Biagioni, Fabio Naro, Mauro Giorgi, Michele Saliola
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	International Journal of Molecular Sciences
Subjects:	cGMP-specific phosphodiesterase glycolytic/respiratory flux <i>Kluyveromyces lactis</i> redox balance rag phenotype
Online Access:	https://www.mdpi.com/1422-0067/23/15/8587

Similar Items

Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis
by: Silvia Cardarelli, et al.
Published: (2017-09-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Once upon a Testis: The Tale of Cyclic Nucleotide Phosphodiesterase in Testicular Cancers
by: Federica Campolo, et al.
Published: (2023-04-01)

Optogenetic manipulation of cyclic guanosine monophosphate to probe phosphodiesterase activities in megakaryocytes
by: Yujing Zhang, et al.
Published: (2022-08-01)

Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential
by: William J. Moss, et al.
Published: (2024-02-01)

Characterization and Modification of Light-Sensitive Phosphodiesterases from Choanoflagellates
by: Yuehui Tian, et al.
Published: (2022-01-01)

Role of Phosphodiesterase in the Biology and Pathology of Diabetes
by: Agnieszka Kilanowska, et al.
Published: (2020-11-01)

Advances, Perspectives and Potential Engineering Strategies of Light-Gated Phosphodiesterases for Optogenetic Applications
by: Yuehui Tian, et al.
Published: (2020-10-01)

Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia
by: Nadja I. Bork, et al.
Published: (2021-12-01)

Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
by: Miaomiao Jiang, et al.
Published: (2023-08-01)

Cardiorenal Effects of Long‐Term Phosphodiesterase V Inhibition in Pre–Heart Failure
by: Scott A. Hubers, et al.
Published: (2022-01-01)

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
by: Ahmed K. ElHady, et al.
Published: (2023-09-01)

Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies
by: Diego Montoya-Durango, et al.
Published: (2023-10-01)

Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in Toxoplasma gondii
by: Kim Chi Vo, et al.
Published: (2022-01-01)

Phosphodiesterases regulate BAY 41-2272-induced VASP phosphorylation in vascular smooth muscle cells
by: Shaquria P Adderley, et al.
Published: (2012-02-01)

The Effects of Acute and Chronic Selective Phosphodiesterase 1 Inhibition on Smooth Muscle Cell-Associated Aging Features
by: Keivan Golshiri, et al.
Published: (2022-01-01)

Compartmentation of cGMP Signaling in Induced Pluripotent Stem Cell Derived Cardiomyocytes during Prolonged Culture
by: Maria Faleeva, et al.
Published: (2022-10-01)

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
by: Roberta Kurelic, et al.
Published: (2021-10-01)

In Search of Monocot Phosphodiesterases: Identification of a Calmodulin Stimulated Phosphodiesterase from <i>Brachypodium distachyon</i>
by: Mateusz Kwiatkowski, et al.
Published: (2021-09-01)

Functions of PDE3 Isoforms in Cardiac Muscle
by: Matthew Movsesian, et al.
Published: (2018-02-01)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
by: Wolfgang Kreisel, et al.
Published: (2020-08-01)

The Sleep Quality- and Myopia-Linked PDE11A-Y727C Variant Impacts Neural Physiology by Reducing Catalytic Activity and Altering Subcellular Compartmentalization of the Enzyme
by: Irina Sbornova, et al.
Published: (2023-12-01)

Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
by: John F. Harms, et al.
Published: (2019-08-01)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
by: Claire Lugnier
Published: (2022-09-01)

Effect of phosphodiesterase inhibitors in the bladder
by: Bilal Chughtai, et al.
Published: (2015-01-01)

Multi-Compartment, Early Disruption of cGMP and cAMP Signalling in Cardiac Myocytes from the <i>mdx</i> Model of Duchenne Muscular Dystrophy
by: Marcella Brescia, et al.
Published: (2020-09-01)

Chronic Sildenafil Treatment Improves Vasomotor Function in a Mouse Model of Accelerated Aging
by: Keivan Golshiri, et al.
Published: (2020-06-01)

Sub-nanomolar sensitivity of nitric oxide mediated regulation of cGMP and vasomotor reactivity in vascular smooth muscle
by: Kara F. Held, et al.
Published: (2012-07-01)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
by: Nikoleta Pavlaki, et al.
Published: (2018-01-01)

Corrigendum: Systemic induction of NO-, redox- and cGMP signaling in the pumpkin extrafascicular phloem upon local leaf wounding
by: Frank eGaupels
Published: (2016-03-01)

The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment
by: Alexandra M. Fajardo, et al.
Published: (2014-02-01)

Role of Phosphodiesterase 1 in the Regulation of Real-Time cGMP Levels and Contractility in Adult Mouse Cardiomyocytes
by: Nadja I. Bork, et al.
Published: (2023-12-01)

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation
by: Marie Bielenberg, et al.
Published: (2024-03-01)

Phylogenetic Analysis and Characterization of Diguanylate Cyclase and Phosphodiesterase in Planktonic Filamentous Cyanobacterium <i>Arthrospira</i> sp.
by: Kang Wang, et al.
Published: (2023-10-01)

Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
by: Islam BN, et al.
Published: (2018-08-01)

Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G
by: Pilar Monfort, et al.
Published: (2004-02-01)

Effect of aerobic exercise training on cGMP levels and blood pressure in treated hypertensive postmenopausal women
by: Iane P Novais, et al.

Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease
by: Fubiao Shi, et al.
Published: (2023-07-01)

Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer
by: Patrizia Di Iorio, et al.
Published: (2021-12-01)

Identification of new signaling components in the sensory epithelium of human saccule
by: Eva eDegerman, et al.
Published: (2011-08-01)